OLSSON SHAWN (Chief Commercial Officer) sold 67.9% of their position (10K shares) of LENZ THERAPEUTICS, INC. on the open market
Open‑market sale worth $261.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/19/2025ACC: 0002015796-25-000003
Officer· Chief Commercial Officer
Since Mar 2024
-10K
Net shares
Net seller
$261.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+10K
Price / share
$2.08
Trade value
$20.80K
% of position
211.3%
11/17/2025
4.73K→14.73K
Common Stock
Direct
Shares
−4.21K
Price / share
$25.74
Trade value
$108.41K
% of position
28.6%
11/17/2025
14.73K→10.52K
Common Stock
Direct
Shares
−5.79K
Price / share
$26.37
Trade value
$152.61K
% of position
55.0%
11/17/2025
10.52K→4.73K
Total
Net shares
+0.00
Net value
-$240.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | M · Option Exercise | +10K | $2.08 | $20.80K | 211.3% | 4.73K | 14.73K |
| Common Stock Direct | 11/17/2025 | S · Sale | −4.21K | $25.74 | $108.41K | 28.6% | 14.73K | 10.52K |
| Common Stock Direct | 11/17/2025 | S · Sale | −5.79K | $26.37 | $152.61K | 55.0% | 10.52K | 4.73K |
| Total | +0.00 | -$240.22K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
2.08
Held after
53.24K
Exercisable
—
11/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10K shares | 11/17/2025 | M · Option Exercise | −10K | 2.08 | — | 53.24K |